10-18441439-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_201596.3(CACNB2):​c.333+39396C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.359 in 151,984 control chromosomes in the GnomAD database, including 10,059 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 10059 hom., cov: 32)

Consequence

CACNB2
NM_201596.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.463

Publications

11 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • cardiogenetic disease
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.497 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.333+39396C>T
intron
N/ANP_963890.2Q08289-1
CACNB2
NM_201590.3
MANE Plus Clinical
c.171+39396C>T
intron
N/ANP_963884.2Q08289-3
CACNB2
NM_201597.3
c.333+39396C>T
intron
N/ANP_963891.1Q08289-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.333+39396C>T
intron
N/AENSP00000320025.8Q08289-1
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.171+39396C>T
intron
N/AENSP00000366546.4Q08289-3
CACNB2
ENST00000352115.10
TSL:1
c.333+39396C>T
intron
N/AENSP00000344474.6Q08289-8

Frequencies

GnomAD3 genomes
AF:
0.358
AC:
54444
AN:
151866
Hom.:
10044
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.435
Gnomad AMI
AF:
0.373
Gnomad AMR
AF:
0.290
Gnomad ASJ
AF:
0.344
Gnomad EAS
AF:
0.512
Gnomad SAS
AF:
0.266
Gnomad FIN
AF:
0.303
Gnomad MID
AF:
0.329
Gnomad NFE
AF:
0.331
Gnomad OTH
AF:
0.358
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.359
AC:
54497
AN:
151984
Hom.:
10059
Cov.:
32
AF XY:
0.355
AC XY:
26388
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.435
AC:
18043
AN:
41458
American (AMR)
AF:
0.290
AC:
4421
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.344
AC:
1190
AN:
3462
East Asian (EAS)
AF:
0.513
AC:
2650
AN:
5166
South Asian (SAS)
AF:
0.265
AC:
1278
AN:
4814
European-Finnish (FIN)
AF:
0.303
AC:
3199
AN:
10556
Middle Eastern (MID)
AF:
0.320
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
0.331
AC:
22512
AN:
67946
Other (OTH)
AF:
0.365
AC:
771
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1761
3522
5282
7043
8804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.341
Hom.:
30986
Bravo
AF:
0.365
Asia WGS
AF:
0.404
AC:
1406
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.4
DANN
Benign
0.45
PhyloP100
-0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7069923; hg19: chr10-18730368; API